NCT07823543

Brief Summary

The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Dec 2027

First Submitted

Initial submission to the registry

December 14, 2025

Completed
9 months until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

September 16, 2026

Status Verified

September 1, 2026

Enrollment Period

1.2 years

First QC Date

December 14, 2025

Last Update Submit

September 12, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • TSH Compliance Rate

    The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are \< 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%

    Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12

  • Patient satisfaction

    Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).

    Immediately after the educational presentation (post-intervention)

Secondary Outcomes (4)

  • Level of knowledge dissemination

    Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12

  • Patient anxiety level

    Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total

  • Patient's Level of Regret After Surgery

    Baseline (before the educational outreach) and immediately after the educational outreach

  • Incidence of adverse events in patients

    Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6

Study Arms (2)

Intervention group

EXPERIMENTAL

Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines

Other: Thyroid Surgery Educational Video

Non-intervention group

NO INTERVENTION

Without any additional intervention

Interventions

Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer created by researchers based on guidelines

Intervention group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients scheduled for thyroid surgery, aged between 18 and 60 years old

You may not qualify if:

  • Unable to read and write, pregnant, or with a history of thyroid surgery;
  • suffering from other malignant tumors or mental disorders;
  • unable to complete the questionnaire independently or requiring assistance from others.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid Nodule

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Accepting educational videos on thyroid health produced by researchers in accordance with guidelines
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 14, 2025

First Posted

September 16, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

September 16, 2026

Record last verified: 2026-09